Abbott Laboratories to pay $670 million over infant formula claims
Abbott Laboratories will pay $670 million to settle cases and claims involving formula for premature babies.
By DoomRadar · Published on DoomRadar .
Why it matters
The settlement concerns alleged risks involving medically vulnerable infants and may affect confidence in infant nutrition products.
Related source links
These links were collected with this event. Recorded source dates may reflect when a link was found. Article publication dates are shown only when available from the source. Open the originals for their full context.
- Abbott Laboratories to pay $670 million to settle cases, claims over its formula for premature babies ↗pottsmerc.com · Recorded source date: Aug 21, 2026, 12:31 AM UTC
- Abbott Laboratories to pay $670 million to settle cases, claims over its formula for premature babies ↗dailycamera.com · Recorded source date: Aug 21, 2026, 2:02 AM UTC
- Abbott Laboratories to pay $670 million to settle cases, claims over its formula for premature babies ↗courant.com · Recorded source date: Aug 21, 2026, 2:17 AM UTC
- Abbott Laboratories to pay $670 million to settle cases, claims over its formula for premature babies ↗coloradohometownweekly.com · Recorded source date: Aug 21, 2026, 2:32 AM UTC
- Abbott Laboratories to pay $670 million to settle cases, claims over its formula for premature babies ↗lowellsun.com · Recorded source date: Aug 21, 2026, 2:32 AM UTC
AI-assisted, source-based analysis. Methodology · Report a correction